News
Qosina, a global supplier of OEM single-use components, has expanded its partnership with the Bioprocess Solutions business ...
Bora Pharmaceuticals Co. Ltd. has installed a filling line from Norden Machinery at its Mississauga, Ontario manufacturing ...
TurboFil has been named the exclusive U.S. distributor for Ravona, a manufacturer of aseptic and containment isolation ...
Tobin Scientific, a provider of cGMP-compliant warehousing and transportation solutions, has opened its newest cGMP warehouse ...
Farwell succeeds Jordan Dubow, who will continue to serve as a consultant and chair of the Clinical Advisory Board.
LogiCare3PL, a division of BioCare Inc., has partnered with ChiRhoClin Inc., a leader in pancreatic and gastrointestinal ...
The U.S. FDA has accepted a Biologics License Application (BLA) for BAT2506, a proposed biosimilar to Simponi (golimumab).
Thermo Fisher Scientific Inc. has expanded its strategic partnership with Sanofi to enable additional U.S. drug product manufacturing.
Zhaoke Ophthalmology Limited has reached a memorandum of agreement (MOA) with Fareva, a French contract manufacturing ...
IL Group, a specialist in multifunctional labeling solutions for the pharmaceutical and healthcare sectors, has introduced ...
Evestia Clinical ( formerly known as EMAS Pharma) has merged with Atlantic Research Group (ARG), a US-based CRO, to create an ...
RZL-012 is an injectable treatment for focal fat reduction that is currently progressing toward Phase 3 trials.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results